2013
DOI: 10.2494/photopolymer.26.161
|View full text |Cite
|
Sign up to set email alerts
|

pH-Sensitive Polymeric Micelles for Enhanced Intracellular Anti-cancer Drug Delivery

Abstract: Polyion complex (PIC) micelles are expected to be used as nanocarrier for drug delivery. The PIC micelles formed by cationic anti-cancer drug, doxorubicin (DOX) and poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) (PEG-b-PVBP) (DOX@PNP) was prepared with different pH conditions and composition ratio of the mixture. DOX and PEG-b-PVBP were spontaneously self-assembled in aqueous solutions into nanoparticles with average size of 45-55 nm over the entire range of the compositions of the mixtures includi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…Kamimura et al 88 synthesized polyionic complex micelles from poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) (PEG-b-PVBP) loaded with DOX as pH-sensitive nanocarriers (DOX@PNP). These self-assembled NPs (45–55 nm) overcame the premature drug release problem by hydrophobic and electrostatic interactions between phosphonate groups of PEG-b-PVBP as hydrophobic segments and cationic DOX.…”
Section: Ph-sensitive Nanocarriersmentioning
confidence: 99%
See 1 more Smart Citation
“…Kamimura et al 88 synthesized polyionic complex micelles from poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) (PEG-b-PVBP) loaded with DOX as pH-sensitive nanocarriers (DOX@PNP). These self-assembled NPs (45–55 nm) overcame the premature drug release problem by hydrophobic and electrostatic interactions between phosphonate groups of PEG-b-PVBP as hydrophobic segments and cationic DOX.…”
Section: Ph-sensitive Nanocarriersmentioning
confidence: 99%
“…99 However, they have some limitations such as low encapsulation efficiency, too rapid a release rate of the drug, low storage stability and lack of tunable triggers for drug release. 100 As a result, several investigations have focused on enhancing liposome stability and circulation half-life, for example by surface modification, and assembly of layer-by-layer liposomal NPs (LBL-LNPs) 88 to improve targeting and drug release. pH-Sensitive liposomes including various pH-sensitive components have been designed to release the active contents from the inside the endosomes into the cytoplasm.…”
Section: Ph-sensitive Nanocarriersmentioning
confidence: 99%
“…Although a lot of attention has been paid to the drug delivery with fluorescence imaging guidance, not much research includes the fluorescence tracking of gene delivery. For the sake of real-time tracking of the gene delivery and transfection, fluorescence tags including fluorescent proteins, organic dyes, and nanoparticles (NPs) can be covalently labeled to the gene.…”
mentioning
confidence: 99%
“…[2][3][4] To a certain extent, nano-DDS can solve many problems associated with drug molecules like low drug solubility, fast clearance rates, non-specific toxicity, thereby enhancing therapeutic efficiency and reducing side effects. [5,6] Common DDS include liposomes, [7][8][9] mesoporous silicon, [10][11][12] polymer micelles, [13][14][15] hydrogels. [16,17] Among them, liposomes have received widespread attention due to their biocompatibility, degradability and ability to encapsulate various drugs.…”
Section: Introductionmentioning
confidence: 99%